"next target"? has been a target since inception. At Moderna or BioNtech Cancer and Gene Therapy were priorities during the last decade or so, with limited evidence of success as far as I can tell. Infectious disease is scientific low hanging fruit for this approach, but has been less attractive commercial opportunities, so received limited focus on that until SARS-COV-2. The did a good job executing on the vaccines,…
It's a large proof of concept on the safe use of mRNA. Sure, any given implementation might be harmful, but this is (so far) showing that it is not in itself a harmful process. And there'll be mountains of cash poured into mRNA research now, so if cancer treatment is a viable path, there's a reasonable chance of some success here. But it won't be a cure-all. We use "cancer" as if it were a single disease, but it's re…
Until about a year ago, potential treatments took 5-10 years of safety testing before general population use. This stuff takes time for things like antibody-dependent enhancement to be found.
What we do know is those who are obese have bad outcomes to C19. I am not obese, got it a couple months ago, and recovered with just home rest. Now I test positive for the antibodies.